Chronic Liver Diseases

Chronic liver disease (CLD) is a major concern for the U.S. with the rates of morbidity and mortality on the rise since 2005. CLD includes multiple pathologies such as inflammation, fibrosis, cirrhosis and cancer, and can be induced by multiple liver disorders including hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, cholangiopathies (i.e. diseases that target the biliary epithelial cells), and others. One of the main treatments for CLD is liver transplantation, but the number livers available for transplant is decreasing as the number of people awaiting a transplant is increasing. Therefore, it is of the utmost importance to identify new therapeutic targets for the treatment of CLD.

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
Nimmi Anna
Journal Manager
Allied Journal of Medical Research
Email: medicalresearch@emedsci.com